Futura Medical (LON:FUM) Stock Price Up 10.3% – Still a Buy?

Shares of Futura Medical plc (LON:FUM) were up 10.3% on Friday . The company traded as high as GBX 0.42 and last traded at GBX 0.42. 3,594,404 shares traded hands during trading, a decline of 63% from the average session volume of 9,689,350 shares. The stock had previously closed at GBX 0.38.

Futura Medical Trading Up 10.3%

The firm has a market capitalization of £2.43 million, a price-to-earnings ratio of -0.15 and a beta of 0.02. The business’s fifty day moving average price is GBX 0.53 and its 200 day moving average price is GBX 0.94.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The firm had revenue of GBX 170 million during the quarter. As a group, sell-side analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.